BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 16548334)

  • 1. Passive protection of dogs against clinical disease due to Canine parvovirus-2 by specific antibody from chicken egg yolk.
    Van Nguyen S; Umeda K; Yokoyama H; Tohya Y; Kodama Y
    Can J Vet Res; 2006 Jan; 70(1):62-4. PubMed ID: 16548334
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vaccination with canine parvovirus type 2 (CPV-2) protects against challenge with virulent CPV-2b and CPV-2c.
    Siedek EM; Schmidt H; Sture GH; Raue R
    Berl Munch Tierarztl Wochenschr; 2011; 124(1-2):58-64. PubMed ID: 21306055
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Canine parvovirus type 2 vaccine protects against virulent challenge with type 2c virus.
    Spibey N; Greenwood NM; Sutton D; Chalmers WS; Tarpey I
    Vet Microbiol; 2008 Apr; 128(1-2):48-55. PubMed ID: 18006253
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of Chicken IgY Generated Against Canine Parvovirus Viral-Like Particles and Development of Enzyme-Linked Immunosorbent Assay and Immunochromatographic Assay for Canine Parvovirus Detection.
    He J; Wang Y; Sun S; Zhang X
    Viral Immunol; 2015 Nov; 28(9):489-94. PubMed ID: 26469376
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibody levels and protection to canine parvovirus type 2.
    Elia G; Cavalli A; Cirone F; Lorusso E; Camero M; Buonavoglia D; Tempesta M
    J Vet Med B Infect Dis Vet Public Health; 2005; 52(7-8):320-2. PubMed ID: 16316392
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Maternally-derived antibodies in pups and protection from canine parvovirus infection.
    Decaro N; Campolo M; Desario C; Elia G; Martella V; Lorusso E; Buonavoglia C
    Biologicals; 2005 Dec; 33(4):261-7. PubMed ID: 16168665
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum distemper virus and parvovirus antibody titers among dogs brought to a veterinary hospital for revaccination.
    McCaw DL; Thompson M; Tate D; Bonderer A; Chen YJ
    J Am Vet Med Assoc; 1998 Jul; 213(1):72-5. PubMed ID: 9656027
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Canine parvovirus: recent knowledge of the origin and development of a viral pathogen].
    Truyen U
    Tierarztl Prax; 1994 Dec; 22(6):579-84. PubMed ID: 7716757
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Do two current canine parvovirus type 2 and 2b vaccines provide protection against the new type 2c variant?
    Larson LJ; Schultz RD
    Vet Ther; 2008; 9(2):94-101. PubMed ID: 18597247
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of selected canine vaccines for their ability to induce protective immunity against canine parvovirus infection.
    Larson LJ; Schultz RD
    Am J Vet Res; 1997 Apr; 58(4):360-3. PubMed ID: 9099379
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of serum antibody titers against canine distemper virus, canine adenovirus type II, and canine parvovirus in Alaskan sled dogs before and after a long-distance race.
    Banse HE; McKenzie EC; Nelson S; Hinchcliff KW
    J Am Vet Med Assoc; 2008 Jun; 232(11):1669-73. PubMed ID: 18518808
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Three-year serologic immunity against canine parvovirus type 2 and canine adenovirus type 2 in dogs vaccinated with a canine combination vaccine.
    Larson LJ; Schultz RD
    Vet Ther; 2007; 8(4):305-10. PubMed ID: 18183549
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Faecal shedding of canine parvovirus after modified-live vaccination in healthy adult dogs.
    Freisl M; Speck S; Truyen U; Reese S; Proksch AL; Hartmann K
    Vet J; 2017 Jan; 219():15-21. PubMed ID: 28093104
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the antigenic relationships among canine parvovirus type 2 variants.
    Cavalli A; Martella V; Desario C; Camero M; Bellacicco AL; De Palo P; Decaro N; Elia G; Buonavoglia C
    Clin Vaccine Immunol; 2008 Mar; 15(3):534-9. PubMed ID: 18160619
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence for immunisation failure in vaccinated adult dogs infected with canine parvovirus type 2c.
    Decaro N; Desario C; Elia G; Martella V; Mari V; Lavazza A; Nardi M; Buonavoglia C
    New Microbiol; 2008 Jan; 31(1):125-30. PubMed ID: 18437851
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of positive antibody test results for canine parvovirus (CPV) and canine distemper virus (CDV) and response to modified live vaccination against CPV and CDV in dogs entering animal shelters.
    Litster A; Nichols J; Volpe A
    Vet Microbiol; 2012 May; 157(1-2):86-90. PubMed ID: 22261239
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of the paramunity inducer PIND-ORF in the treatment of canine parvovirus infection.
    Proksch AL; Unterer S; Truyen U; Hartmann K
    Vet J; 2014 Nov; 202(2):340-7. PubMed ID: 25218850
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Canine Parvovirus is diagnosed and neutralized by chicken IgY-scFv generated against the virus capsid protein.
    Ge S; Xu L; Li B; Zhong F; Liu X; Zhang X
    Vet Res; 2020 Sep; 51(1):110. PubMed ID: 32883344
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Three-year duration of immunity in dogs following vaccination against canine adenovirus type-1, canine parvovirus, and canine distemper virus.
    Gore TC; Lakshmanan N; Duncan KL; Coyne MJ; Lum MA; Sterner FJ
    Vet Ther; 2005; 6(1):5-14. PubMed ID: 15906266
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of two assays for detection of antibodies against canine parvovirus and canine distemper virus in dogs admitted to a Florida animal shelter.
    Gray LK; Crawford PC; Levy JK; Dubovi EJ
    J Am Vet Med Assoc; 2012 May; 240(9):1084-7. PubMed ID: 22515628
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.